Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

AIDS vaccine delivers

17.01.2002


The HIV virus: killing cells laden with these particles may form a key part of future AIDS vaccination strategies.
© SPL


Cellular attack tactic keeps virus at bay.

A new AIDS vaccine could be one of the most promising yet. The drug’s effects in monkeys suggest that killing virus-laden cells may form a key part of future vaccination strategies.

Vaccinated monkeys survived a usually lethal infection with a monkey-human hybrid virus, SHIV. Their primed immune system kept virus levels below detection, Emilio Emini of Merck Research Laboratories in West Point, Pennsylvania, and his team now report1. The results are some of the most encouraging to come out of AIDS vaccine research.



But doubts have already been voiced. Low-lying virus can change to elude the immune response, argue Dan Barouch of Harvard Medical School in Boston and his team. A year after they gave eight animals a similar vaccination, a mutant form of the virus emerged, killing one of the monkeys2.

"This finding should be a reality check rather than a death knell," Barouch says, adding that the technique can be modified to block the emergence of mutant viruses. Future attempts could hit several different SIV proteins to prevent the virus escaping. Both of the latest vaccines targeted a single protein.

Emini is already pursuing this goal. But like multi-drug-resistant bacteria, HIV could conceivably outwit even a broadly targeted vaccine, although this is less likely. Whether the vaccines tested in the monkeys will be as effective in humans, however, is unknown.

Troubled history

AIDS is notoriously difficult to vaccinate against. Initial attempts took a conventional approach by injecting a single HIV surface protein to trigger the animals’ immune system into producing antibodies that would attack the virus during a subsequent infection. But HIV evades antibodies by hiding the proteins that the antibodies latch onto and by evolving new strains.

"HIV turned out to be much more complicated," says vaccine researcher Jeffrey Lifson of the National Cancer Institute at Frederick, Maryland. In the past few years, vaccine hunters have switched to a different tack that simulates the way the body naturally attempts to deal with HIV infection - namely, stimulating the immune system to strike virus-infected cells.

Emini’s team achieved this by using a harmless virus to deliver SIV DNA direct to specific immune cells. "It looks encouraging," says Lifson.

Unfortunately, as with any vaccine that keeps virus levels in check, rather than preventing infection, there is the risk that the pathogen will re-emerge. "It’s an ominous question to ask about the whole strategy," comments Lifson. Nonetheless, such a vaccine could in theory defer the onset of AIDS and cut the risk of HIV spreading.

The antibody approach may still bear fruit if it can hit essential, unchanging parts of the virus. Meanwhile, the ultimate ideal remains a vaccine that triggers both arms of the immune system - antibodies and cell attack.

References

  1. Shiver, J. W. et al. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature, 415, 331 - 335, (2002).
  2. Barouch, D. H. et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature, 415, 335 - 339, (2002).

HELEN PEARSON | © Nature News Service

More articles from Health and Medicine:

nachricht Routing gene therapy directly into the brain
07.12.2017 | Boston Children's Hospital

nachricht New Hope for Cancer Therapies: Targeted Monitoring may help Improve Tumor Treatment
01.12.2017 | Berliner Institut für Gesundheitsforschung / Berlin Institute of Health (BIH)

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists channel graphene to understand filtration and ion transport into cells

Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.

To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...

Im Focus: Towards data storage at the single molecule level

The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.

Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...

Im Focus: Successful Mechanical Testing of Nanowires

With innovative experiments, researchers at the Helmholtz-Zentrums Geesthacht and the Technical University Hamburg unravel why tiny metallic structures are extremely strong

Light-weight and simultaneously strong – porous metallic nanomaterials promise interesting applications as, for instance, for future aeroplanes with enhanced...

Im Focus: Virtual Reality for Bacteria

An interdisciplinary group of researchers interfaced individual bacteria with a computer to build a hybrid bio-digital circuit - Study published in Nature Communications

Scientists at the Institute of Science and Technology Austria (IST Austria) have managed to control the behavior of individual bacteria by connecting them to a...

Im Focus: A space-time sensor for light-matter interactions

Physicists in the Laboratory for Attosecond Physics (run jointly by LMU Munich and the Max Planck Institute for Quantum Optics) have developed an attosecond electron microscope that allows them to visualize the dispersion of light in time and space, and observe the motions of electrons in atoms.

The most basic of all physical interactions in nature is that between light and matter. This interaction takes place in attosecond times (i.e. billionths of a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

AKL’18: The opportunities and challenges of digitalization in the laser industry

07.12.2017 | Event News

 
Latest News

Midwife and signpost for photons

11.12.2017 | Physics and Astronomy

How do megacities impact coastal seas? Searching for evidence in Chinese marginal seas

11.12.2017 | Earth Sciences

PhoxTroT: Optical Interconnect Technologies Revolutionized Data Centers and HPC Systems

11.12.2017 | Information Technology

VideoLinks
B2B-VideoLinks
More VideoLinks >>>